liproxstatin-1 and Subarachnoid-Hemorrhage

liproxstatin-1 has been researched along with Subarachnoid-Hemorrhage* in 1 studies

Other Studies

1 other study(ies) available for liproxstatin-1 and Subarachnoid-Hemorrhage

ArticleYear
Selective Ferroptosis Inhibitor Liproxstatin-1 Attenuates Neurological Deficits and Neuroinflammation After Subarachnoid Hemorrhage.
    Neuroscience bulletin, 2021, Volume: 37, Issue:4

    Ferroptosis is a form of iron-dependent regulated cell death. Evidence of its existence and the effects of its inhibitors on subarachnoid hemorrhage (SAH) is still lacking. In the present study, we found that liproxstatin-1 protected HT22 cells against hemin-induced injury by protecting mitochondrial functions and ameliorating lipid peroxidation. In in vivo experiments, we demonstrated the presence of characteristic shrunken mitochondria in ipsilateral cortical neurons after SAH. Moreover, liproxstatin-1 attenuated the neurological deficits and brain edema, reduced neuronal cell death, and restored the redox equilibrium after SAH. The inhibition of ferroptosis by liproxstatin-1 was associated with the preservation of glutathione peroxidase 4 and the downregulation of acyl-CoA synthetase long-chain family member 4 as well as cyclooxygenase 2. In addition, liproxstatin-1 decreased the activation of microglia and the release of IL-6, IL-1β, and TNF-α. These data enhance our understanding of cell death after SAH and shed light on future preclinical studies.

    Topics: Animals; Ferroptosis; Quinoxalines; Rats; Rats, Sprague-Dawley; Spiro Compounds; Subarachnoid Hemorrhage

2021